Finally, using a well-established Drosophila melanogaster model for Huntington’s disease (Q128HD-FL), which expresses the mutated form of human huntingtin, the neuronal function improved after MS3 treatment, definitively proving the in vivo efficacy of this aptamer. This evidence concerns the gene HTT and Huntington disease.